DNA polymorphisms as tools for spinal cord injury research

Spinal Cord

Volumn 47, Issue 2, 2009, Pages 171-175

  Guimaraes P E M ^a   Fridman, C ^a   Gregorio S P ^a   Kalil, E M ^a   Cristante, A F ^a   Teixeira, W G J ^a   Rodrigues, C J ^a   Costa, M C R ^b   Gattaz, W F ^a   Barros, T E P ^a   Oliveira, P S L ^a   Dias Neto, E ^a,c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF RIBEIRÃO PRETO   (Brazil)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

ALOX12; APOE; BDNF; NINJ1; Single nucleotide polymorphism; Spinal cord injury

Indexed keywords

APOLIPOPROTEIN E; ARACHIDONATE 12 LIPOXYGENASE; BRAIN DERIVED NEUROTROPHIC FACTOR; CELL PROTEIN; PROTEIN NINJ1; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BRAZIL; CLINICAL ARTICLE; CONTROLLED STUDY; GENE FREQUENCY; GENE IDENTIFICATION; GENE MAPPING; GENOTYPE; HUMAN; INFLAMMATION; MEDICAL RESEARCH; NERVE GROWTH; NERVOUS SYSTEM DEVELOPMENT; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SPINAL CORD INJURY;

EID: 59749091090     PISSN: 13624393     EISSN: 14765624     Source Type: Journal    
DOI: 10.1038/sc.2008.67     Document Type: Article

References (24)

1. Klussmann S, Martin-Villalba A. Molecular targets in spinal cord injury. J Mol Med 2005; 83: 657-671.
2. Kwon BK, Borisoff JF, Tetzlaff W. Molecular targets for therapeutic intervention after spinal cord injury. Mol Interv 2002; 2: 244-258.
3. Blight AR. Miracles and molecules-progress in spinal cord repair. Nat Neurosci 2002; 5: 1051-1054.
4. Brookes AJ. The essence of SNPs. Gene 1999; 234: 177-186.
5. Stranger BE, Forrest MS, Dunning M, Ingle CE, Beazley C, Thorne N et al. Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science 2007; 315: 848-853.
6. Mishra PJ, Humeniuk R, Mishra PJ, Longo-Sorbello GS, Banerjee D, Bertino JR. A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance. Proc Natl Acad Sci USA 2007; 104: 13513-13518.
7. Hull J, Campino S, Rowlands K, Chan MS, Copley RR, Taylor MS et al. Identification of common genetic variation that modulates alternative splicing. PLoS Genet 2007; 3: e99.
8. Wang Z, Moult J. SNPs, protein structure, and disease. Hum Mutat 2001; 17: 263-270.
9. Kimchi-Sarfaty C, Oh JM, Kim IW, Sauna ZE, Calcagno AM, Ambudkar SV et al. A 'silent' polymorphism in the MDR1 gene changes substrate specificity. Science 2007; 315: 525-528.
10. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990; 31: 545-548.
11. Cardoso CC, Martinez AN, Guimarães PE, Mendes CT, Pacheco AG, de Oliveira RB et al. Ninjurin 1 asp110ala single nucleotide polymorphism is associated with protection in leprosy nerve damage. J Neuroimmunol 2007; 190: 131-138.
12. Fridman C, Ojopi EP, Gregório SP, Ikenaga EH, Moreno DH, Demetrio FN et al. Association of a new polymorphism in ALOX12 gene with bipolar disorder. Eur Arch Psychiatry Clin Neurosci 2003; 253: 40-43.
13. Sachidanandam R, Weissman D, Schmidt SC, Kakol JM, Stein LD, Marth G et al. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 2001; 409: 928-933.
14. McPherson R, Pertsemlidis A, Kavaslar N, Stewart A, Roberts R, Cox DR et al. A common allele on chromosome 9 associated with coronary heart disease. Science 2007; 316: 1488-1491.
15. Helgadottir A, Thorleifsson G, Magnusson KP, Grétarsdottir S, Steinthorsdottir V, Manolescu A et al. The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm. Nat Genet 2008; 40: 217-224.
16. Brennan P. Gene-environment interaction and aetiology of cancer: what does it mean and how can we measure it? Carcinogenesis 2002; 23: 381-387.
17. Saher G, Brügger B, Lappe-Siefke C, Möbius W, Tozawa R, Wehr MC et al. High cholesterol level is essential for myelin membrane growth. Nat Neurosci 2005; 8: 468-475.
18. Conrad DJ. The arachidonate 12/15 lipoxygenases. A review of tissue expression and biologic function. Clin Rev Allergy Immunol 1999; 17: 71-89.
19. Amer RK, Pace-Asciak CR, Mills LR. A lipoxygenase product, hepoxilin A(3), enhances nerve growth factor-dependent neurite regeneration post-axotomy in rat superior cervical ganglion neurons in vitro. Neuroscience 2003; 116: 935-946.
20. Higuchi Y, Tanii H, Koriyama Y, Mizukami Y, Yoshimoto T. Arachidonic acid promotes glutamate-induced cell death associated with necrosis by 12- lipoxygenase activation in glioma cells. Life Sci 2007; 80: 1856-1864.
21. Mocchetti I, Wrathall JR. Neurotrophic factors in central nervous system trauma. J Neurotrauma 1995; 12: 853-870.
22. Kobayashi NR, Fan DP, Giehl KM, Bedard AM, Wiegand SJ, Tetzlaff W. BDNF and NT-4/5 prevent atrophy of rat rubrospinal neurons after cervical axotomy, stimulate GAP-43 and Talpha1-tubulin mRNA expression, and promote axonal regeneration. J Neurosci 1997; 17: 9583-9595.
23. Jin Y, Fischer I, Tessler A, Houle JD. Transplants of fibroblasts genetically modified to express BDNF promote axonal regeneration from supraspinal neurons following chronic spinal cord injury. Exp Neurol 2002; 177: 265-275.
24. Kubo T, Yamashita T, Yamaguchi A, Hosokawa K, Tohyama M. Analysis of genes induced in peripheral nerve after axotomy using cDNA microarrays. J Neurochem 2002; 82: 1129-1136.